Ken Griffin Thermo Fisher Scientific Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$528.82 - $599.43 $33.9 Million - $38.4 Million	64,100 Added 22.84%	344,800 $200 Million
Q4 2023 Feb 14, 2024	SELL	$431.41 - $532.94 $25.2 Million - $31.1 Million	-58,300 Reduced 17.2%	280,700 $149 Million
Q3 2023 Nov 14, 2023	SELL	$498.29 - $574.41 $39.6 Million - $45.7 Million	-79,500 Reduced 19.0%	339,000 $172 Million
Q2 2023 Aug 14, 2023	BUY	$508.46 - $591.13 $32 Million - $37.2 Million	63,000 Added 17.72%	418,500 $218 Million
Q1 2023 May 15, 2023	SELL	$535.0 - $604.82 $33 Million - $37.3 Million	-61,700 Reduced 14.79%	355,500 $205 Million

Q4 2022 Feb 14, 2023	SELL	$484.71 - $571.37 $15.9 Million - $18.7 Million	-32,700 Reduced 7.27%	417,200 $230 Million
Q3 2022 Nov 14, 2022	BUY	$507.19 - $604.49 $25.2 Million - $30 Million	49,700 Added 12.42%	449,900 $228 Million

2,723

331M

1.58M

2.01M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $217B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.